Introduction to Advanced Therapy Medicinal Products (ATMPs) in the EU

EIC – EMA Info Day: Regulatory support for the development of innovative medicines and technologies

Standardizing traceability of personalized cell and gene therapies

S1 Overview of EMA-approved anti-cancer products

EU Market Authorisation strategy: Lessons from the first 22 ATMP submitted to the EMA

EU ATMPs Quality Regulation

Early Go-To-Market Considerations for Cell & Gene Therapies

EMA & EATRIS present: ADVANCE webinar on support for academic and non-profit ATMP developers

FDA EMA clinical immunogenicity safety assessments first video

EMA & EATRIS present: Scientific Advice for Advanced Therapy Medicinal Products: What & When to Ask

Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing

Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

Guidance on process-related impurity analysis of cell and gene therapies | Complexity explained

Epithelial Stem Cells and Combined Cell and Gene Therapy - Breaking News in Stem Cells

How to monitor impurities and ensure consistent cell & gene therapies

IPA programme – 1st training – Human products parallel session

Session 2 Cell and Gene Therapy - ENG/한글자막

Commercial and Regulatory Success in Accelerated Gene Therapy Development

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence - AM

Gene Therapy Yesterday, Today and Tomorrow